Arbutus Biopharma (ABUS) Current Leases (2013 - 2026)
Arbutus Biopharma's (ABUS) quarterly Current Leases came in at $631000.0 in Q1 2026, up 12.08% year-on-year from $563000.0 in Q1 2025, and up 15.36% quarter-over-quarter from $547000.0 in Q4 2025.
Arbutus Biopharma (ABUS) Current Leases (2013 - 2026) Analysis & Trends
Arbutus Biopharma has disclosed Current Leases across 11 years of filings, most recently posting $631000.0 for Q1 2026.
- Current Leases for Q1 2026 came in at $631000.0, up 12.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $631000.0 (up 12.08% YoY), and the FY2025 annual result was $547000.0, up 13.25% from the prior year.
- Current Leases came in at $631000.0 for Q1 2026 at Arbutus Biopharma, up from $547000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $631000.0 in Q1 2026 to a low of $360000.0 in Q3 2022.
- The 5-year median for Current Leases is $453000.0 (2024), against an average of $465882.4.
- Across the five-year window, Current Leases retreated 6.74% in 2022 and increased 14.44% in 2023, its largest moves.
- Arbutus Biopharma's Current Leases stood at $372000.0 in 2022, then climbed by 14.25% to $425000.0 in 2023, then rose by 13.65% to $483000.0 in 2024, then climbed by 13.25% to $547000.0 in 2025, then climbed by 15.36% to $631000.0 in 2026.
- The last three Current Leases figures came in at $631000.0 (Q1 2026), $547000.0 (Q4 2025), and $531000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Arbutus Biopharma | 882.62 Mn | 882.62 Mn | - | 631,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 631,000.00 |
| Dec 31, 2025 | 547,000.00 |
| Sep 30, 2025 | 531,000.00 |
| Jun 30, 2025 | 514,000.00 |
| Mar 31, 2025 | 563,000.00 |
| Dec 31, 2024 | 483,000.00 |
| Sep 30, 2024 | 468,000.00 |
| Jun 30, 2024 | 453,000.00 |
| Mar 31, 2024 | 502,000.00 |
| Dec 31, 2023 | 425,000.00 |
| Sep 30, 2023 | 412,000.00 |
| Jun 30, 2023 | 397,000.00 |
| Mar 31, 2023 | 446,000.00 |
| Dec 31, 2022 | 372,000.00 |
| Sep 30, 2022 | 360,000.00 |
| Jun 30, 2022 | 377,000.00 |
| Mar 31, 2022 | 439,000.00 |
| Dec 31, 2021 | 383,000.00 |
| Sep 30, 2021 | 386,000.00 |
| Jun 30, 2021 | 357,000.00 |